This paper is in the following e-collection/theme issue:

COVID-19 Vaccination (179) Vaccination and Immunization in the Digital Age (442) Infectious Diseases (non-STD/STI) (1726) Hygiene and Infection Prevention (374) Public Health (247) Immunoinformatics and Pathology informatics (18)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49812, first published .
Predicting Efficacies of Fractional Doses of Vaccines by Using Neutralizing Antibody Levels: Systematic Review and Meta-Analysis

Predicting Efficacies of Fractional Doses of Vaccines by Using Neutralizing Antibody Levels: Systematic Review and Meta-Analysis

Predicting Efficacies of Fractional Doses of Vaccines by Using Neutralizing Antibody Levels: Systematic Review and Meta-Analysis

Authors of this article:

Zhanwei Du1, 2 Author Orcid Image ;   Caifen Liu1, 2 Author Orcid Image ;   Yuan Bai1, 2 Author Orcid Image ;   Lin Wang3 Author Orcid Image ;   Wey Wen Lim1 Author Orcid Image ;   Eric H Y Lau1, 2 Author Orcid Image ;   Benjamin J Cowling1, 2 Author Orcid Image
Article Authors Cited by (3) Tweetations Metrics

Journals

  1. Bai Y, Ertem Z, Diestra J, Wang L, Du Z. Editorial: Infectious Disease Epidemiology and Transmission Dynamics 2.0. Viruses 2024;16(8):1223 View
  2. Çolak S, İlgar T, Bahçeci İ, Özkaya E, Hüner Yiğit M, Durmuş H, Atiş F, Ertürk A, Yazıcı Z. Clinical Significance of Neutralizing Antibodies in COVID-19: Implications for Disease Prognosis. Life 2025;15(3):429 View
  3. Caraco Y, Madar-Balakirski N, Ben-Ami E, Zeltser D, Maayan S, Eliakim-Raz N, Peer A, Brosh-Nissimov T, Vishlitzky V, Beth-Din A, Bar-Haim E, Israely T, Paran N, Fisher M, Hoggeg M, Atsmon J, Cohen D, Goldstaub D, Levin Y, Danon Y, Panet A, Shapira S, Yitzhaki S, Marcus H. Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults. Vaccine 2025;67:127837 View